NCT00462592View on ClinicalTrials.gov

Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Asthma
Interventions
DRUG

budesonide

inhaled budesonide turbuhaler 200ug taken 1 puff morning \& 1 puff evening.

DRUG

montelukast

montelukast 5 mg ( \< 15 years) or 10 mg (and matching placebo)will be taken 1 tab in the evening

OTHER

placebo

placebo

Trial Locations (2)

L8N 3Z5

Hamilton Health Sciences-McMaster University, Hamilton

M5G 1X8

Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Hamilton Health Sciences Corporation

OTHER

NCT00462592 - Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction | Biotech Hunter | Biotech Hunter